Related Experiment Videos
Sirolimus-induced acneiform eruption
N Kunzle1, J-P Venetz, M Pascual
1Department of Dermatology and Venerology, DHURDV, Lausanne, Switzerland.
Dermatology (Basel, Switzerland)
|November 16, 2005
Summary
Sirolimus can cause severe acneiform eruptions in kidney transplant patients. This skin condition often requires stopping sirolimus treatment for resolution.
Area of Science:
- Nephrology
- Dermatology
- Immunology
Background:
- Sirolimus is an immunosuppressant used in renal transplantation to avoid calcineurin inhibitors.
- Cutaneous side effects of sirolimus are not fully understood and may be underestimated.
Observation:
- Two cases of renal allograft recipients developed follicular acneiform eruptions.
- The dermatologic complication was severe and challenging to manage.
Findings:
- Sirolimus-induced acneiform eruptions are a significant adverse event.
- Discontinuation of sirolimus led to the resolution of the skin condition.
Implications:
- Clinicians should be aware of potential severe skin reactions to sirolimus.
- Monitoring for and managing dermatologic side effects is crucial in sirolimus-treated patients.
- Further research into sirolimus's cutaneous effects is warranted.